Director Manuel C. Alves Aivado resigns from Rein Therapeutics board effective Feb 16

Rein Therapeutics, Inc.

Manuel C. Alves Aivado, M.D., Ph.D., resigned as board member effective February 16, 2026.
Resignation was not the result of any disagreement with the company's operations, policies, or practices.
No replacement has been announced; board size and composition subsequent to departure not disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.